How to Buy Wave Life Sciences Stock
Wave Life Sciences Ltd
Wave Life Sciences Ltd. , a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform.
Wave Life Sciences stock last closed at $5.92, up 1.37% from the previous day, and has increased 23.59% in one year. It has overperformed other stocks in the Biotechnology industry by 1.02 percentage points. Wave Life Sciences stock is currently +39.29% from its 52-week low of $4.25, and -64.63% from its 52-week high of $16.74.
At the moment, there are 153.49M shares of WVE outstanding. The market capitalization of WVE is $908.64M. In the last 24 hours, 948,105 WVE shares were traded.
How to Buy Wave Life Sciences Stock
Not sure how to invest in Wave Life Sciences stock? Here's how.
- Choose where to buy Wave Life Sciences stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Wave Life Sciences stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your method of payment and add your details.
- Research Wave Life Sciences stock: The Wave Life Sciences ticker symbol is WVE. Is Wave Life Sciences stock a good investment? Should you buy shares of WVE? How do WVE's underlying business fundamentals look? Do top analysts think Wave Life Sciences is a good buy? Why has WVE's stock price moved recently? (Hint: Our stock research website can help you evaluate if WVE is a good stock to buy).
- Place your WVE trade: Decide if you will purchase WVE shares at the current market price or use a limit order to buy WVE shares at a particular price.
- Keep an eye on your investment in WVE: Create a watchlist to get the latest news on your new investment in Wave Life Sciences stock.
Step 1: Choose where to buy Wave Life Sciences stock
You need an online brokerage account to access the NASDAQ market and buy WVE shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, you need to fill out some personal information so you are able to invest in WVE today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new brokerage account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the best stock app, your next step is to transfer the money for your investment:
Watch the video below for more details transferring money into your investment account.
Step 4: Research Wave Life Sciences stock
After you have identified the best place to buy Wave Life Sciences stock, it's absolutely critical to analyze their stock prior to investing, so you truly understand the risk and upside.
Wave Life Sciences quick stats
WVE Due Diligence Score
WallStreetZen was built to help part-time investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on WVE's stock page.
Is WVE stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge WVE's fair value.
Using relative valuations methods:
- WVE could be overvalued based on its P/B ratio of 4.34x, relative to Biotechnology industry P/B ratio of 4.05x
You can access more valuation analysis on WVE's stock here.
WVE Financial Health
Positive Financial Indicators:
- WVE has cash burn of 151964000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the WVE balance sheet.
- Total WVE debt is lower than 5 years ago, relative to shareholder equity.
- WVE has $302.08M in cash and short term investments. This is enough to cover its annual cash burn of $151.96M.
- There are more short-term assets than short-term liabilities on the WVE balance sheet.
Negative Financial Indicators:
- WVE profit margin has gone down from -50.8% to -89.6% in the past year.
- WVE has a relatively high debt to equity ratio of 0.64.
Is it a good time to buy Wave Life Sciences stock, according to Wall Street analysts?
Out of 6 Equities analysts who give forecasts on WVE, the consensus analyst rating on Wave Life Sciences is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Latest WVE Analyst Upgrades/Downgrades
Luca Issi, a bottom 2% analyst from RBC Capital maintains WVE with a hold rating and raises their WVE price target from $7.00 to $15.00, on Oct 21, 2024.
You can dig deeper into what analysts are saying on the Wave Life Sciences stock forecast page.
WVE Trading Indicators
WVE Performance Numbers
Last year, WVE revenue was $108.30M. During the last five year, WVE's revenue has increased by 46.62% per year. This was faster than the Biotechnology industry average of 44.43%.
Dive into WVE's earnings and revenue performance here.
Who is buying/selling WVE?
Over the past year, executives and large shareholders at WVE have bought more shares than they have sold.
Christian O. Henry, Director of WVE, was the latest WVE insider to buy. They bought $95,865.00 worth of WVE shares on Mar 20, 2025.
Learn more about who owns WVE stock here.
Does WVE stock generate passive income?
No, Wave Life Sciences doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your WVE trade
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine for most investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at an exact price, place a limit order.
Press the Open button and your broker will place your order.
If you want additional help buying stocks on eToro, click the how to video below:
Step 6: Keep an eye on your investment in WVE
Now that you own some WVE stock, you'll want to keep up with your new investment.
Make a watchlist to keep tabs on your WVE stock.
WVE Feed
How to Buy Stock in Wave Life Sciences
To reiterate, here are the 6 steps for buying Wave Life Sciences stock:
- Choose where to buy Wave Life Sciences stock
- Create a brokerage account
- Fund your brokerage account
- Research Wave Life Sciences stock
- Place your WVE trade
- Keep an eye on your investment in WVE
If you require a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Wave Life Sciences, get started below.
Related Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.